The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer

By Karagol Hakan   Saip Pinar   Uygun Kazim   Caloglu Murat   Eralp Yesim   Tas Faruk   Aydiner Adnan   Topuz Erkan  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 39-43

Humana Press, Inc

Access to resources Recommend Favorite

Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By Nielsen H.A.   Nielsen D.   Engelholm S.A.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

By Tung N.   Berkowitz R.   Matulonis U.   Quartulli M.   Seiden M.   Kim Y.   Niloff J.   Cannistra S.A.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 8, 2012-10 ,pp. : 982-987

Bentham Science Publishers

Access to resources Recommend Favorite

Phase II Trial of Topotecan, Carboplatin, and Paclitaxel as Front-Line Therapy in Suboptimal Advanced Epithelial Ovarian Cancer

By Bolis G.   Scarfone G.   Villa A.   Parazzini F.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 331-333

Elsevier

Access to resources Recommend Favorite